The Alzheimer Biomarkers Consortium-Down Syndrome (ABC-DS) works to better understand Alzheimer’s in adults with Down syndrome by identifying sensitive neuropsychological measures of cognitive decline, blood-based proteins, metabolites and genetic biomarkers, along with neuropathological features. Visit ABC-DS' new, revamped website to learn more at abc-ds.org.
Publish Date